MedRestrictions

(PI: JING LUO)

Coverage, Formulary Restrictions, and Out-of-Pocket Costs for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Medicare Part D Program

Link to manuscript: 10.1001/jamanetworkopen.2020.20969

This cross-sectional study assessed drug coverage, formulary restrictions, median retail prices, and annual out-of-pocket costs for beneficiaries filling either an SGLT2 inhibitor or GLP-1 receptor agonist prescription in Medicare Part D.

Luo J, Feldman R, Rothenberger SD, Hernandez I, Gellad WF. Coverage, Formulary Restrictions, and Out-of-Pocket Costs for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Medicare Part D Program. JAMA Netw Open. 2020 Oct 1;3(10):e2020969. doi: 10.1001/jamanetworkopen.2020.20969. PMID: 33057641; PMCID: PMC7563069.